Pfizer acquires Metsera in $10 billion deal after competitive bidding with Novo Nordisk

Pfizer Inc. has agreed to buy Metsera Inc. for $10 billion, surpassing Novo Nordisk in a competitive bidding war. Details of ...

Metsera accepts Pfizer's $10 billion acquisition bid in ongoing M&A battle

Pfizer appeared to have locked up the acquisition in September before Novo jumped in last week with an unsolicited offer, ...
NewsBytes

Pfizer to acquire Metsera for $10B, beating out Novo Nordisk

Metsera, an obesity drug developer, has accepted a $10 billion acquisition offer from pharmaceutical giant Pfizer, potentially concluding a bidding war with Novo Nordisk.

Pfizer And Metsera Enter Into Merger Agreement Amendment Metsera's Board Of Directors Reaffirms Support Of Merger With Pfizer

Pfizer And Metsera Enter Into Merger Agreement Amendment Metsera's Board Of Directors Reaffirms Support Of Merger With Pfizer. <li /> Revised transaction values Metsera at up to $86.25 per share <li ...